Genomics BioSci & Tech. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	96.11	138.3	172.58	253.03	317	107.5
Short-Term Investments	56.53	34.6	65	-	-	-
Cash & Short-Term Investments	152.64	172.9	237.58	253.03	317	107.5
Cash Growth	-13.87%	-27.23%	-6.11%	-20.18%	194.90%	-81.30%
Accounts Receivable	154.28	183.71	138.86	116.1	100.02	81.75
Other Receivables	0.25	0.44	0.39	0.74	0.01	1.44
Receivables	154.53	184.15	139.25	116.84	100.02	83.2
Inventory	236.52	235.82	185.49	61.51	54.8	20.99
Prepaid Expenses	19.4	14.11	18.09	16.85	8.83	21.92
Other Current Assets	7.41	32.39	34.77	23.58	17.45	18.23
Total Current Assets	570.5	639.36	615.19	471.82	498.1	251.83
Property, Plant & Equipment	628.83	648.09	648.43	498.69	373.37	311.02
Long-Term Investments	109.34	99.79	74.65	153.98	237.96	285.83
Other Intangible Assets	6.93	6.54	5.77	1.73	0.86	1.16
Long-Term Accounts Receivable	-	-	0.64	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	-	0.07
Other Long-Term Assets	12.1	32.34	15.68	7.63	9.44	3.27
Total Assets	1,328	1,426	1,360	1,134	1,120	853.18
Accounts Payable	73.25	125.67	97.4	29.73	40.47	27.31
Accrued Expenses	-	42.54	35.4	28.7	34.5	27.54
Short-Term Debt	279.29	250.11	128.96	50	50	-
Current Portion of Long-Term Debt	61.76	60.87	35.41	4.86	12.4	3.9
Current Portion of Leases	6.09	6.5	6.43	6.51	4.75	3.39
Current Income Taxes Payable	-	-	-	-	0.58	-
Current Unearned Revenue	35.03	33.44	43.69	12.72	20	18.89
Other Current Liabilities	44.13	14.18	35.48	13.57	6.21	13.57
Total Current Liabilities	499.56	533.3	382.77	146.09	168.91	94.59
Long-Term Debt	285.63	301.47	328.89	214.01	153.35	75.67
Long-Term Leases	7.97	9.3	7.98	8.24	8.34	3.58
Total Liabilities	793.16	844.07	719.64	368.33	330.6	173.84
Common Stock	724.48	724.48	724.48	724.48	630.28	578.92
Additional Paid-In Capital	-	1.07	30.15	131.53	58.91	43.76
Retained Earnings	-252.41	-213.33	-204.06	-88.24	101.85	36.07
Comprehensive Income & Other	-0.53	-1.87	-1.84	-2.25	-1.91	20.59
Total Common Equity	471.55	510.34	548.73	765.51	789.13	679.34
Minority Interest	63	71.72	91.99	-	-	-
Shareholders' Equity	534.55	582.07	640.73	765.51	789.13	679.34
Total Liabilities & Equity	1,328	1,426	1,360	1,134	1,120	853.18
Total Debt	640.75	628.25	507.67	283.61	228.84	86.53
Net Cash (Debt)	-488.1	-455.35	-270.08	-30.58	88.17	20.96
Net Cash Growth	-	-	-	-	320.57%	-95.42%
Net Cash Per Share	-6.72	-6.29	-3.73	-0.43	1.39	0.35
Filing Date Shares Outstanding	72.35	72.45	72.45	72.45	64.29	60.23
Total Common Shares Outstanding	72.35	72.45	72.45	72.45	64.29	60.23
Working Capital	70.95	106.06	232.42	325.73	329.19	157.24
Book Value Per Share	6.52	7.04	7.57	10.57	12.27	11.28
Tangible Book Value	464.61	503.8	542.96	763.78	788.27	678.18
Tangible Book Value Per Share	6.42	6.95	7.49	10.54	12.26	11.26
Land	-	206.74	206.74	139.79	104.76	104.76
Buildings	-	266.04	256.36	211.33	144.63	134.61
Machinery	-	315.59	234.39	231.91	142.81	150.45
Construction In Progress	-	-	52.59	0.23	79.45	26.25
Leasehold Improvements	-	1.01	-	-	-	-